Health sciences

SQZ Biotech to Present at BofA Securities 2021 Virtual Health Care Conference

Retrieved on: 
Wednesday, May 5, 2021
Biotechnology, Infectious diseases, Health, Pharmaceutical, Oncology, Life sciences, Branches of biology, Health sciences, Stem cells, Biotechnology, Cell biology, Cell therapy, Therapy

b'SQZ Biotechnologies (NYSE:SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that management will be participating in the BofA (Bank of America) Securities 2021 Virtual Health Care Conference taking place May 11-13, 2021.

Key Points: 
  • b'SQZ Biotechnologies (NYSE:SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that management will be participating in the BofA (Bank of America) Securities 2021 Virtual Health Care Conference taking place May 11-13, 2021.
  • The webcast will be available for 90 days following the presentation.\nSQZ Biotechnologies is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions.
  • SQZ Biotechnologies has the potential to create well-tolerated cell therapies that can provide therapeutic benefit for patients and to improve the patient experience over existing cell therapy approaches.
  • With accelerated production timelines under 24 hours and the opportunity to eliminate preconditioning and lengthy hospital stays, our goal is to use the SQZ approach to establish a new paradigm for cell therapies.

Dentists Improve Health in Cornelius, NC by Replacing Missing Teeth with Dental Implants

Retrieved on: 
Wednesday, May 5, 2021
Dentistry, Health sciences, Health care, Restorative dentistry, Prosthetics, Prosthodontology, Oral surgery, Dental implant, Dentist, Human tooth, Outline of dentistry and oral health

Committed to helping their community maintain excellent overall health, they welcome new patients with damaged or missing teeth in Cornelius, NC to receive dental implant consultations with or without a referral.\nDrs.

Key Points: 
  • Committed to helping their community maintain excellent overall health, they welcome new patients with damaged or missing teeth in Cornelius, NC to receive dental implant consultations with or without a referral.\nDrs.
  • White and Haines have extensive experience placing dental implants using precision-planning technology, while Dr. Papp brings a unique whole-body philosophy to dentistry with her osteopathic medicine background.
  • Besides being comfortable and durable, the biggest advantage of implants is that they are most like your original teeth.
  • White, Haines, and Papp are members of the American Dental Association and Charlotte Dental Society, among many others.

StudyKIK Announces New Website for Clinical Trial Patient Recruitment Platform with Services Including eConsent, Telemedicine, & Study Retention Mobile Apps

Retrieved on: 
Wednesday, May 5, 2021
Articles, Health sciences, Pharmaceutical industry, Health, Clinical research, Clinical trials, Advertising, Patient recruitment, Recruitment, Telehealth, Research site, Clinical trial portal

StudyKIK has been supporting many of the top pharmaceutical companies over the past 7 years with patient recruitment and more recently with digital trial services like eConsent, telemedicine, and study companion mobile applications.\nFrom its inception StudyKIK has been focused on providing a safe and trusted way for people to join a clinical trial.

Key Points: 
  • StudyKIK has been supporting many of the top pharmaceutical companies over the past 7 years with patient recruitment and more recently with digital trial services like eConsent, telemedicine, and study companion mobile applications.\nFrom its inception StudyKIK has been focused on providing a safe and trusted way for people to join a clinical trial.
  • Like research sites, CRO and Sponsors who partner with StudyKIK can also access recruitment, enrollment, and retention data from a single interface.
  • "\nAs StudyKIK continues to grow it\'s offerings in the pharma services space, its new website and platform will be the first choice for those looking to join, or manage, a clinical trial.\nStudyKIK is a full service patient recruitment and retention technology company that offers Patient Recruitment, Patient Retention, eConsent, Telemedicine, and Study Companion Mobile Apps to ensure study timelines are met.
  • As a result, StudyKIK is the global leader in patient recruitment and retention strategy and the trusted place for millions of people looking to join a clinical trial.\n'

Grocery Workers in Vancouver Coastal Health and Fraser Health to Receive Priority Access to COVID-19 Vaccines

Retrieved on: 
Wednesday, May 5, 2021
Medical research, COVID-19, COVID-19 vaccine, Health sciences, Medicine, Health in Mexico, Deployment of COVID-19 vaccines, COVID-19 vaccination in Russia

Many workers in industrial food settings and home care have already received their first doses of the vaccine.

Key Points: 
  • Many workers in industrial food settings and home care have already received their first doses of the vaccine.
  • Now, workers in grocery and retail in the affected health regions will have one more layer of protection against COVID-19.\nIf you are a grocery worker in the Vancouver Coastal Health or Fraser Health regions, scroll down to learn how you can get your vaccine:\nOn the registration page, enter your personal and contact information.
  • The access code needs to be entered twice and is case sensitive.\nIn the fillable box identify: Grocery Store/Warehouse\nUFCW 1518 strongly recommends that all front-line workers get vaccinated against COVID-19.
  • All COVID-19 vaccines are safe and effective and will help to protect you and your co-workers.

Aquestive Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update

Retrieved on: 
Wednesday, May 5, 2021
Health sciences, Health, Pharmaceutical industry, Food and Drug Administration, Clinical research, Design of experiments, United States Public Health Service, Clinical trial

As a result of these issues, a large portion of the patient population does not receive adequate treatment or foregoes treatment altogether.

Key Points: 
  • As a result of these issues, a large portion of the patient population does not receive adequate treatment or foregoes treatment altogether.
  • Since September, Aquestive has engaged with the FDA and developed a plan to address the deficiencies noted in the CRL.
  • Aquestive continues to believe that no additional clinical studies will be required to resubmit the NDA.
  • Shipment volume has grown 13% sequentially quarter over quarter and 40% year over year.

Large Study Analyzes Two Different Classes of ADHD Drugs in Preschool-Age Children

Retrieved on: 
Tuesday, May 4, 2021
Health sciences, Childhood psychiatric disorders, Health, Psychiatry, Attention deficit hyperactivity disorder, Amphetamine, Methylphenidate, Medication, Pharmaceutical industry, Stimulant, Prescription drug

The researchers found that both classes of drugs have benefits, with differing side effects, suggesting that decisions on which class of drugs to prescribe should be made based on individual patient factors.

Key Points: 
  • The researchers found that both classes of drugs have benefits, with differing side effects, suggesting that decisions on which class of drugs to prescribe should be made based on individual patient factors.
  • In contrast, children aged 5 to younger than 6 prescribed were likely to continue using the medication for longer if they were prescribed a stimulant.
  • "Future research should seek to learn more about the use of these classes of drugs in preschool-age children so that we can prescribe the most effective therapy for each patient.
  • In addition, its unique family-centered care and public service programs have brought the 595-bed hospital recognition as a leading advocate for children and adolescents.

Athenex to Acquire Kuur Therapeutics to Expand Cell Therapy Development with Off-the-Shelf Engineered CAR-NKT Platform

Retrieved on: 
Tuesday, May 4, 2021
Health sciences, Branches of biology, Clinical medicine, Cancer immunotherapy, Immune system, Tyrosine kinases, Medicinal chemistry, Therapy, Chimeric antigen receptor T cell, Tyrosine-protein kinase CSK

\xe2\x80\x9cKuur\xe2\x80\x99s innovative technology, combined with our TCR program, could propel us into a leadership position in cell therapy.

Key Points: 
  • \xe2\x80\x9cKuur\xe2\x80\x99s innovative technology, combined with our TCR program, could propel us into a leadership position in cell therapy.
  • Dan Lang, President of Athenex Cell Therapy, added, \xe2\x80\x9cWe are thrilled to combine our TCR program with the groundbreaking NKT cell platform developed by Professor Leonid Metelitsa at Baylor College of Medicine and Texas Children\xe2\x80\x99s Hospital.
  • The patient with the PR had previously failed autologous CAR-T cell therapy.
  • The Company\xe2\x80\x99s current clinical pipeline is derived from four different platform technologies: (1) Orascovery, based on P-glycoprotein inhibitor, (2) Src kinase inhibition, (3) Cell therapy, and (4) Arginine deprivation therapy.

Small Pharma Inc. to Commence Trading on the TSX Venture Exchange on May 6, 2021

Retrieved on: 
Tuesday, May 4, 2021
Health sciences, Health, Communication, Forward-looking statement, Clinical trial, Articles

Forward-looking statements in this news release include statements regarding the Company\xe2\x80\x99s success in launching a clinical program into DMT-assisted therapy.

Key Points: 
  • Forward-looking statements in this news release include statements regarding the Company\xe2\x80\x99s success in launching a clinical program into DMT-assisted therapy.
  • In disclosing the forward-looking information contained in this press release, the Company has made certain assumptions.
  • Any references to quality, consistency, efficacy and safety of potential therapies do not imply that Small Pharma verified such in clinical trials or that Small Pharma will complete such trials.
  • Small Pharma\xe2\x80\x99s securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the \xe2\x80\x9cU.S.

UIC Law Launches Social Equity Cannabis Initiative with Attorney S.L. Owens

Retrieved on: 
Tuesday, May 4, 2021
Herbalism, Medicinal plants, Health sciences, Cannabis in Illinois, Illinois Cannabis Regulation and Tax Act, Cannabis, Medical cannabis, Branches of biology, Medicine

Owens has joined the Community Enterprise & Solidarity Economy Clinic at UIC John Marshall Law School as its newest staff attorney.

Key Points: 
  • Owens has joined the Community Enterprise & Solidarity Economy Clinic at UIC John Marshall Law School as its newest staff attorney.
  • Owens will lead the Social Equity Cannabis Initiative, designed by the CESEC in partnership with the Illinois Department of Commerce and Economic Opportunity.
  • from the University of Wisconsin-Madison, where she received a U.S. Fulbright Fellowship.\nUnder the Social Equity Cannabis Initiative, the CESEC provides the following services to help Social Equity Applicants understand the Illinois Cannabis Regulation and Tax Act and other cannabis-related laws: legal representation; brief advising; and legal technical assistance workshops.
  • \xe2\x80\x9cS.L.\xe2\x80\x99s knowledge, cannabis law experience and life-long connection to social equity communities here in Chicago are an invaluable asset to the growth and success of the Initiative and UIC Law students.\xe2\x80\x9d\nUIC Law is the 16th college at the University of Illinois at Chicago\xe2\x80\x94Chicago\xe2\x80\x99s largest university and its only public Carnegie Research 1 institution.

Poll: Blacks Report BDO "Very Helpful" in Vaccine Decision

Retrieved on: 
Tuesday, May 4, 2021
Medicine, Health sciences, Vaccine hesitancy, Medical specialties, COVID-19 vaccine, Vaccine, COVID-19 vaccines, Clinical trials, COVID-19 vaccination in Bulgaria, COVID-19 vaccination in the United States

b'CHICAGO, May 4, 2021 /PRNewswire/ -- BlackDoctor.org (BDO) has been leading the charge in COVID-19 vaccine education since the beginning of the pandemic.

Key Points: 
  • b'CHICAGO, May 4, 2021 /PRNewswire/ -- BlackDoctor.org (BDO) has been leading the charge in COVID-19 vaccine education since the beginning of the pandemic.
  • That\'s over two-thirds of over 1600 respondents saying that BDO helped their decision to get vaccinated.
  • BDO polled their audience throughout the pandemic to gauge attitudes and concerns about the vaccines and identified a significant shift.
  • Vaccine hesitancy by Blacks was averaging around 60% but later dropped down to only 22% saying they will not get the vaccine.\nBDO recognized Blacks need information about when, where, and how to get the vaccine.